Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
Recruiting
N/A
Interventional Study
Lung Cancer Screening
Tobacco Use Disorder
Smoking Cessation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 250 (estimated)
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* African American
* 20+ pack years of smoking
* eligible for or received LDCT screening
* current smoker
* English speaking
Exclusion Criteria:
* N/A
Contacts